Biotechnology - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

101 to 125 of 998 results

Teijin and Amgen join forces on autoimmune disease research

31-07-2013

Japan's Teijin Pharma, the core company of the Teijin Group's (TSE: 3401) health care business, has entered…

AmgenBiotechnologyImmunologicalsInflammatory diseasesLicensingPharmaceuticalResearchTeijin

Cancer drug sales reps find access to oncologist most restricted

31-07-2013

Oncology remains the most restrictive specialty for pharmaceutical sales representative access this year…

BiotechnologyMarkets & MarketingNorth AmericaOncologyPharmaceutical

Health care M&A spending grows in 2nd-qtr 2013, says Irving Levin

30-07-2013

Health care merger and acquisition activity strengthened in the second quarter of 2013. (View full video:…

BiotechnologyMergers & AcquisitionsPharmaceutical

Adocia re-acquires exclusive rights to insulin analog from US drug major

30-07-2013

French biotech firm Adocia (Euronext Paris: ADOC) has agreed with US pharma major Eli Lilly (NYSE: LLY)…

AdociaBiotechnologyDiabetesEli LillyLicensingPharmaceutical

Bristol-Myers partners with South Korean firm on biopharma production

29-07-2013

US pharma major Bristol-Myers Squibb (NYSE: BMY) has entered into a 10-year agreement under which Samsung…

Asia-PacificBiotechnologyBristol-Myers SquibbOncologyPharmaceuticalProductionSamsung BioLogics

HAI Europe questions pharma commitment to clinical trial data transparency, claiming leaked documents suggest otherwise

29-07-2013

Consumer advocacy Health Action International (HAI) Europe says it welcomes any initiative that grants…

BiotechnologyEuropeNorth AmericaPharmaceuticalPoliticsRegulationResearch

EU Commission investigates alleged aid to German Pharma

29-07-2013

The European Commission revealed last week that it has opened an in-depth investigation to verify whether…

BiotechnologyEuropeFinancialPharmaceuticalPricing

Vertex slumps as FDA delays hepatitis C trial

26-07-2013

US drug maker Vertex Pharmaceuticals (Nasdaq: VRTX) saw its shares drop 11% to $78 a share, in after-hours…

Anti-viralsBiotechnologyNorth AmericaPharmaceuticalRegulationResearchVertexVX-135

US orphan designation for defactinib in mesothelioma

25-07-2013

US cancer drug developer Verastem (Nasdaq: VSTM) says that its lead cancer stem cell inhibitor, VS-6063…

BiotechnologydefactinibOncologyPharmaceuticalRegulationResearchVerastem

Strong 1st-half at Roche driven by cancer drug

25-07-2013

Swiss drug major Roche (ROG: SIX) has posted a health set of financial results for the first half of…

BiotechnologyFinancialPharmaceuticalRoche

European and US drugmakers commit to responsible clinical data sharing

24-07-2013

In a joint statement issued this morning (July 24), the European Federation of Pharmaceutical Industries…

BiotechnologyEuropeNorth AmericaPharmaceuticalRegulationResearch

Quest PharmaTech sets up partnership in South Korea

24-07-2013

Canadian cancer specialist Quest PharmaTech (TSX-V: QPT) has entered into a long term strategic relationship…

AD BiotechBiotechnologyFinancialOncologyPharmaceuticalQuest PharmaTechResearch

Galapagos and Servier celebrate late stage discovery milestone

24-07-2013

Belgium-based Galapagos (Euronext: GLPG) has announced a late stage discovery milestone for small molecules…

Anti-Arthritics/RheumaticsBiotechnologyEuropeFinancialGalapagosPharmaceuticalServier

Ligand enters global license deal for women's health product

23-07-2013

Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

UK's NICE calls for more data to consider Roche drug for a type of vasculitis

23-07-2013

UK drug watchdog the National Institute for Health and Care Excellence (NICE) has today (July 23) published…

BiotechnologyEuropeMabTheraOncologyPharmaceuticalPricingRare diseasesRegulationRoche

Bipartisan Bill exempting FDA user fees from sequestration introduced in USA

22-07-2013

A bipartisan group of US House of Representatives Members last week introduced the FDA Safety Over Sequestration…

BiotechnologyFinancialLegalNorth AmericaPharmaceuticalPolitics

Cheaper anti-cancer drug as effective as expensive disease-specific agent in treating wet AMD

21-07-2013

An anti-cancer drug has been proven to be equally as effective in treating the most common cause of blindness…

AvastinBiotechnologyEuropeFinancialLucentisNovartisOphthalmicsPharmaceuticalResearchRoche

Simponi ARIA cleared by US FDA

19-07-2013

US health care giant Johnson & Johnson's (NYSE: JNJ) Janssen Biotech subsidiary has received US Food…

Anti-Arthritics/RheumaticsBiotechnologyJanssen BiotechJohnson & JohnsonNorth AmericaPharmaceuticalRegulationSimponi ARIA

New Zealand consults on Victrelis listing and some Pegasys amendments

19-07-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to list boceprevir…

Anti-viralsAsia-PacificBiotechnologyMerck & CoPegasysPharmaceuticalRegulationRocheVictrelis

UK's NICE recommends hepatitis C treatment for children

18-07-2013

In draft guidance published this week, the UK's drugs watchdog the National Institute for Health and…

Anti-viralsBiotechnologyEuropeMerck & CoPegasysPharmaceuticalPricingRegulationRocheViraferonPeg

Deal between Ensemble and Alexion will target ultra-rare disorders

18-07-2013

USA-based drug discovery firm Ensemble Therapeutics has announced the initiation of a drug discovery…

Alexion PharmaceuticalsBiotechnologyEnsemble TherapeuticsNorth AmericaPharmaceuticalRare diseasesResearch

101 to 125 of 998 results

Back to top